Oncology

Latest News

Offline data augmentation can significantly enhance deep learning techniques, improving classification performance compared to models trained solely on original clinician skin images. | Image Credit: Alexander - stock.adobe.com
Optimized Deep Learning Model Classifies Smartphone Images of Malignant Skin Lesions

May 12th 2025

Across various classes, the researchers identified a model that, when coupled with appropriate data augmentation and optimization partner, may help aid in the detection of skin cancer.

With inconclusive treatment guidance and varying findings from clinical trials, the prognosis of transformed SCLC remains poor. | Image credit: Crystal Light - stock.adobe.com
Whole Exome Sequencing Identifies Distinct Profile of Transformed SCLC

May 12th 2025

The report suggests a TBS cutoff value of 3 will serve as a meaningful prognostic tool in HCC, but differences in patient populations and imaging techniques may affect the value of that cutoff, the authors noted. | Image credit: Jo Panuwat D - stock.adobe.com
HCC Tumor Burden Score Predicts Long-Term Outcomes Following MWA

May 7th 2025

Doctor showing lung x ray | Image credit: didesign – stock.adobe.com
Tarlatamab Safety Varies Between Clinical and Real-World SCLC Trials

May 6th 2025

CureCancer | Image Credit: © MMPhoto21-sotck.adobe.com
COA 2025: Insight, Innovation, and Independent Strength

May 5th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Dr Barbara McAneny Explains the Current Focus of Care Management in Oncology
December 20th 2018

Dr Barbara McAneny Explains the Current Focus of Care Management in Oncology

Keeping people with cancer out of the hospital is a low-hanging fruit that is of huge benefit to patients, explained Barbara L. McAneny, MD, president of the American Medical Association.
Dr Michael Kolodziej Reflects on OCM and What Might Come After
December 19th 2018

Dr Michael Kolodziej Reflects on OCM and What Might Come After

The Oncology Care Model (OCM) is not a sustainable model, but while it finishes out the 5-year pilot, CMS will likely be fine-tuning bundled payments in medical oncology, said Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc.
Report Assesses Degree of Alignment Between ASCO, ESMO Oncology Frameworks
December 18th 2018

Report Assesses Degree of Alignment Between ASCO, ESMO Oncology Frameworks

Allison Inserro
A joint assessment comparing the results of value frameworks created by the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) found that the frameworks produce comparable measures of the clinical benefits of new cancer therapies in roughly two-thirds of more than 100 drug comparisons examined.
Dr Sibel Blau Discusses Physician, Staff Education Around OCM
December 17th 2018

Dr Sibel Blau Discusses Physician, Staff Education Around OCM

Implementing the Oncology Care Model required educating physicians and staff on a new way to do the work and why the changes were necessary under the new model, explained Sibel Blau, MD, medical oncologist at Northwest Medical Specialties, PLLC.
Common Factors Among Successful Practices in the OCM
December 16th 2018

Common Factors Among Successful Practices in the OCM

Laura Joszt, MA
Practices participating in the Oncology Care Model have now received performance results for 2 periods, and many practices were surprised that they didn’t perform as well as expected. In general, some of the practices have found it difficult to predict success in the model, but there have been positive results from the OCM.
Dr Robert Daly Explains the Importance of Updating Pathways With New Data
December 16th 2018

Dr Robert Daly Explains the Importance of Updating Pathways With New Data

As new breakthrough therapies are approved, clinical pathways have to be kept updated in order for patients to get the best treatments, said Robert Daly, MD, MBA, medical oncologist, Memorial Sloan Kettering Cancer Center.
Podcast: This Week in Managed Care—US Uninsured Rate Increases and Other Health News
December 16th 2018

Podcast: This Week in Managed Care—US Uninsured Rate Increases and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Beth Wittmer Discusses Diet Restrictions With Neutropenia
December 15th 2018

Beth Wittmer Discusses Diet Restrictions With Neutropenia

Patients with neutropenia or at risk of it need to be cautious of their diet, said Beth Wittmer, RN, OCN, manager of care management at Florida Cancer Specialists and Research Institute.
Using Cost Variation to Identify Savings Opportunities Under the OCM
December 14th 2018

Using Cost Variation to Identify Savings Opportunities Under the OCM

A study published in this month's issue of The American Journal of Managed Care® estimated standardized episode-level spending for patients across subcategories of care for each hospital referral region—defined by the Dartmouth Atlas—in order to identify the greatest opportunities for cost savings under the Oncology Care Model (OCM).
This Week in Managed Care: December 14, 2018
December 14th 2018

This Week in Managed Care: December 14, 2018

This week, the top managed care news included a report that found uninsured rates were on the rise in 2017; an analysis of rising health insurance costs for families; predictions for cardiology trends in 2019.
Equity in Cancer Care: A Viewpoint From Patient Advocates
December 13th 2018

Equity in Cancer Care: A Viewpoint From Patient Advocates

Jaime Rosenberg
A panel of patient advocates at the National Comprehensive Cancer Network Patient Advocacy Meeting, held in Washington, DC, discussed the reasons behind and consequences of inequities in cancer care.
Adherence With CDK4/6 Inhibitors
December 13th 2018

Adherence With CDK4/6 Inhibitors

Patient Management of CDK4/6 Inhibitors
December 13th 2018

Patient Management of CDK4/6 Inhibitors

Dispensing of CDK4/6 Inhibitors
December 13th 2018

Dispensing of CDK4/6 Inhibitors

Multidisciplinary Approach: Managing CDK4/6 Inhibitors
December 13th 2018

Multidisciplinary Approach: Managing CDK4/6 Inhibitors

Patients' Perspectives on CDK4/6 Inhibitors
December 13th 2018

Patients' Perspectives on CDK4/6 Inhibitors

Benefits and Challenges of CDK4/6 Inhibitors
December 13th 2018

Benefits and Challenges of CDK4/6 Inhibitors

Metastatic Breast Cancer: CDK4/6 Inhibitors
December 13th 2018

Metastatic Breast Cancer: CDK4/6 Inhibitors

Improving Care for Patients With Metastatic Breast Cancer
December 13th 2018

Improving Care for Patients With Metastatic Breast Cancer

Educating Patients and Staff on Using CDK4/6 Inhibitors
December 13th 2018

Educating Patients and Staff on Using CDK4/6 Inhibitors

Best Practices for Managing Patients on CDK4/6 Inhibitors
December 13th 2018

Best Practices for Managing Patients on CDK4/6 Inhibitors

Multidisciplinary Care in Breast Cancer
December 13th 2018

Multidisciplinary Care in Breast Cancer

Considerations for Treating Patients with CDK4/6 Inhibitors
December 13th 2018

Considerations for Treating Patients with CDK4/6 Inhibitors

CDK4/6 Inhibitors in Metastatic Breast Cancer
December 13th 2018

CDK4/6 Inhibitors in Metastatic Breast Cancer

Medically Integrated Pharmacy Teams Spur Innovations
December 13th 2018

Medically Integrated Pharmacy Teams Spur Innovations

Oral Oncolytics and Patient Adherence
December 13th 2018

Oral Oncolytics and Patient Adherence

Medically Integrated Dispensing Service Best Practices
December 13th 2018

Medically Integrated Dispensing Service Best Practices

Practical Challenges in Switching to CDK4/6 Inhibitors
December 13th 2018

Practical Challenges in Switching to CDK4/6 Inhibitors

The Efficacy and Safety of CDK4/6 Inhibitors
December 13th 2018

The Efficacy and Safety of CDK4/6 Inhibitors

Roles of the Oncologist Versus Pharmacist
December 13th 2018

Roles of the Oncologist Versus Pharmacist

<1
...
323334353637383940
...
184>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo